Thursday, October 23, 2014 7:52:11 AM
Now that's extremely laughable,.... why wouldn't organizations or agencies like NIH or WHO count? And I'm not saying that they are among those agencies/organizations with which an MTA is most likely to be made.
First - what IS a MTA (Materials Transfer Agreement)?
Essentially - all an MTA is a written contract that governs the transfer of tangible research materials. An MTA outlines the rights, obligations and restrictions for both the provider and recipient of materials and any derivatives, and any confidential information exchanged with the material.
When IP or 'Trade Secret' information or experimental materials are given out by a company like NNVC to another entity (Like an NIH lab with BSL-4 lab space for example) it's basically a 'cover your butt' document stating what can and cannot be done with those materials, and with whom the information generated or provided can and cannot be openly shared.
Material Transfer Agreements protect the rights of both the receiver and the provider. That's all they are for.
WHO to my knowledge does not have BSL-4 labs of its own in the USA - so my guess is WHO is not going to get an MTA signed off on with NNVC until AFTER an Ebolacide product is available to be distributed IF WHO gets one at all with NNVC.
The list of Agencies or Organizations in the United States with BSL-4 lab space is very short. My guess without doing some digging is that the list of BSL-4 facilities that are approved and equipped to work with live Ebola virus is even shorter. According Wikipedia there were as of 2007 only 15 BSL-4 facilities in the USA, 9 of them in Government Facilities.
http://en.wikipedia.org/wiki/Biosafety_level
Down in the BSL-4 section.
One of these is run by the CDC down in Atlanta. Another in Bethesda run by NIH. Four (one under construction) are on the Ft. Detrick campus in Frederick, MD just outside of DC. A few others scattered about the USA in TX, Boston and one in Montana.
The idea that we don't have a good idea with whom an MTA might go forward even without inside insight is silly.
Expect an MTA, when one appears with one of the labs that is set up to work with Ebola in either the NIH facility, the previously used Army facility at Ft. Detrick, or possibly with the CDC in Atlanta.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM